This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nemerow, G R Articles by Cooper, N R Search for Related Content PubMed PubMed Citation Articles by Nemerow, G R Articles by Cooper, N R

 Previous Article  |  Next Article 

J Virol. 1987 May; 61(5): 1416-1420

Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d.

ABSTRACT

The major Epstein-Barr virus (EBV) envelope glycoprotein, gp350, was purified from the B95-8 cell line and analyzed for its ability to mediate virus attachment to the isolated EBV/C3d receptor (CR2) of human B lymphocytes. Purified gp350 and EBV, but not cytomegalovirus, exhibited dose-dependent binding to purified CR2 in dot blot immunoassays. Binding was inhibited by certain monoclonal antibodies to CR2 and to gp350. Liposomes bearing incorporated gp350 bound to CR2-positive B-cell lines but not to CR2-negative lines. Liposome binding was also inhibited by the OKB7 anti-CR2 monoclonal antibody. A computer-generated comparison of the deduced gp350 amino acid sequence with that of the human C3d complement fragment revealed two regions of significant primary sequence homology, a finding which suggests that a common region on these two unrelated proteins may be involved in CR2 binding.

This article has been cited by other articles:

• Machida, K., Kondo, Y., Huang, J. Y., Chen, Y.-C., Cheng, K. T.-H., Keck, Z., Foung, S., Dubuisson, J., Sung, V. M.-H., Lai, M. M. C. (2008). Hepatitis C Virus (HCV)-Induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope Protein. J. Virol. 82: 6711-6720 [Abstract] [Full Text]  
• Dry, I., Haig, D. M., Inglis, N. F., Imrie, L., Stewart, J. P., Russell, G. C. (2008). Proteomic Analysis of Pathogenic and Attenuated Alcelaphine Herpesvirus 1. J. Virol. 82: 5390-5397 [Abstract] [Full Text]  
• Young, K. A., Chen, X. S., Holers, V. M., Hannan, J. P. (2007). Isolating the Epstein-Barr Virus gp350/220 Binding Site on Complement Receptor Type 2 (CR2/CD21). J. Biol. Chem. 282: 36614-36625 [Abstract] [Full Text]  
• Hutt-Fletcher, L. M. (2007). Epstein-Barr Virus Entry. J. Virol. 81: 7825-7832 [Full Text]  
• Park, S., Lee, J., Ko, Y. H., Han, A., Jun, H. J., Lee, S. C., Hwang, I. G., Park, Y. H., Ahn, J. S., Jung, C. W., Kim, K., Ahn, Y. C., Kang, W. K., Park, K., Kim, W. S. (2007). The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood 110: 972-978 [Abstract] [Full Text]  
• Chua, H.-H., Lee, H.-H., Chang, S.-S., Lu, C.-C., Yeh, T.-H., Hsu, T.-Y., Cheng, T.-H., Cheng, J.-T., Chen, M.-R., Tsai, C.-H. (2007). Role of the TSG101 Gene in Epstein-Barr Virus Late Gene Transcription. J. Virol. 81: 2459-2471 [Abstract] [Full Text]  
• Turk, S. M., Jiang, R., Chesnokova, L. S., Hutt-Fletcher, L. M. (2006). Antibodies to gp350/220 Enhance the Ability of Epstein-Barr Virus To Infect Epithelial Cells. J. Virol. 80: 9628-9633 [Abstract] [Full Text]  
• Jiang, R., Scott, R. S., Hutt-Fletcher, L. M. (2006). Epstein-Barr Virus Shed in Saliva Is High in B-Cell-Tropic Glycoprotein gp42. J. Virol. 80: 7281-7283 [Abstract] [Full Text]  
• Urquiza, M., Lopez, R., Patino, H., Rosas, J. E., Patarroyo, M. E. (2005). Identification of Three gp350/220 Regions Involved in Epstein-Barr Virus Invasion of Host Cells. J. Biol. Chem. 280: 35598-35605 [Abstract] [Full Text]  
• Spaderna, S., Kropff, B., Kodel, Y., Shen, S., Coley, S., Lu, S., Britt, W., Mach, M. (2005). Deletion of gpUL132, a Structural Component of Human Cytomegalovirus, Results in Impaired Virus Replication in Fibroblasts. J. Virol. 79: 11837-11847 [Abstract] [Full Text]  
• Chang, H., Gwack, Y., Kingston, D., Souvlis, J., Liang, X., Means, R. E., Cesarman, E., Hutt-Fletcher, L., Jung, J. U. (2005). Activation of CD21 and CD23 Gene Expression by Kaposi's Sarcoma-Associated Herpesvirus RTA. J. Virol. 79: 4651-4663 [Abstract] [Full Text]  
• Ressing, M. E., van Leeuwen, D., Verreck, F. A. W., Keating, S., Gomez, R., Franken, K. L. M. C., Ottenhoff, T. H. M., Spriggs, M., Schumacher, T. N., Hutt-Fletcher, L. M., Rowe, M., Wiertz, E. J. H. J. (2005). Epstein-Barr Virus gp42 Is Posttranslationally Modified To Produce Soluble gp42 That Mediates HLA Class II Immune Evasion. J. Virol. 79: 841-852 [Abstract] [Full Text]  
• Luna, R. E., Zhou, F., Baghian, A., Chouljenko, V., Forghani, B., Gao, S.-J., Kousoulas, K. G. (2004). Kaposi's Sarcoma-Associated Herpesvirus Glycoprotein K8.1 Is Dispensable for Virus Entry. J. Virol. 78: 6389-6398 [Abstract] [Full Text]  
• Silva, A. L., Omerovic, J., Jardetzky, T. S., Longnecker, R. (2004). Mutational Analyses of Epstein-Barr Virus Glycoprotein 42 Reveal Functional Domains Not Involved in Receptor Binding but Required for Membrane Fusion. J. Virol. 78: 5946-5956 [Abstract] [Full Text]  
• Borza, C. M., Morgan, A. J., Turk, S. M., Hutt-Fletcher, L. M. (2004). Use of gHgL for Attachment of Epstein-Barr Virus to Epithelial Cells Compromises Infection. J. Virol. 78: 5007-5014 [Abstract] [Full Text]  
• Santoro, F., Greenstone, H. L., Insinga, A., Liszewski, M. K., Atkinson, J. P., Lusso, P., Berger, E. A. (2003). Interaction of Glycoprotein H of Human Herpesvirus 6 with the Cellular Receptor CD46. J. Biol. Chem. 278: 25964-25969 [Abstract] [Full Text]  
• McShane, M. P., Mullen, M. M., Haan, K. M., Jardetzky, T. S., Longnecker, R. (2003). Mutational Analysis of the HLA Class II Interaction with Epstein-Barr Virus Glycoprotein 42. J. Virol. 77: 7655-7662 [Abstract] [Full Text]  
• Wong, M., Pagano, J. S., Schiller, J. T., Tevethia, S. S., Raab-Traub, N., Gruber, J. (2002). New Associations of Human Papillomavirus, Simian Virus 40, and Epstein-Barr Virus with Human Cancer. JNCI J Natl Cancer Inst 94: 1832-1836 [Full Text]  
• Rivailler, P., Cho, Y.-g., Wang, F. (2002). Complete Genomic Sequence of an Epstein-Barr Virus-Related Herpesvirus Naturally Infecting a New World Primate: a Defining Point in the Evolution of Oncogenic Lymphocryptoviruses. J. Virol. 76: 12055-12068 [Abstract] [Full Text]  
• Grinstein, S., Preciado, M. V., Gattuso, P., Chabay, P. A., Warren, W. H., De Matteo, E., Gould, V. E. (2002). Demonstration of Epstein-Barr Virus in Carcinomas of Various Sites. Cancer Res. 62: 4876-4878 [Abstract] [Full Text]  
• Prota, A. E., Sage, D. R., Stehle, T., Fingeroth, J. D. (2002). The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding. Proc. Natl. Acad. Sci. USA 99: 10641-10646 [Abstract] [Full Text]  
• Pertel, P. E. (2002). Human Herpesvirus 8 Glycoprotein B (gB), gH, and gL Can Mediate Cell Fusion. J. Virol. 76: 4390-4400 [Abstract] [Full Text]  
• Rivailler, P., Jiang, H., Cho, Y.-g., Quink, C., Wang, F. (2002). Complete Nucleotide Sequence of the Rhesus Lymphocryptovirus: Genetic Validation for an Epstein-Barr Virus Animal Model. J. Virol. 76: 421-426 [Abstract] [Full Text]  
• Birkmann, A., Mahr, K., Ensser, A., Titgemeyer, F., Fleckenstein, B., Neipel, F. (2001). Cell Surface Heparan Sulfate Is a Receptor for Human Herpesvirus 8 and Interacts with Envelope Glycoprotein K8.1. J. Virol. 75: 11583-11593 [Abstract] [Full Text]  
• Young, S. M. Jr., Samulski, R. J. (2001). Adeno-associated virus (AAV) site-specific recombination does not require a Rep-dependent origin of replication within the AAV terminal repeat. Proc. Natl. Acad. Sci. USA 10.1073/pnas.241508998v1 [Abstract] [Full Text]  
• Maruo, S., Yang, L., Takada, K. (2001). Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells. J. Gen. Virol. 82: 2373-2383 [Abstract] [Full Text]  
• Lee, W., Hwang, Y.-H., Lee, S.-K., Subramanian, C., Robertson, E. S. (2001). An Epstein-Barr Virus Isolated from a Lymphoblastoid Cell Line Has a 16-Kilobase-Pair Deletion Which Includes gp350 and the Epstein-Barr Virus Nuclear Antigen 3A. J. Virol. 75: 8556-8568 [Abstract] [Full Text]  
• Sarrias, M. R., Franchini, S., Canziani, G., Argyropoulos, E., Moore, W. T., Sahu, A., Lambris, J. D. (2001). Kinetic Analysis of the Interactions of Complement Receptor 2 (CR2, CD21) with Its Ligands C3d, iC3b, and the EBV Glycoprotein gp350/220. J. Immunol. 167: 1490-1499 [Abstract] [Full Text]  
• Walport, M. J. (2001). Complement- First of Two Parts. NEJM 344: 1058-1066 [Full Text]  
• Tierney, R., Kirby, H., Nagra, J., Rickinson, A., Bell, A. (2000). The Epstein-Barr Virus Promoter Initiating B-Cell Transformation Is Activated by RFX Proteins and the B-Cell-Specific Activator Protein BSAP/Pax5. J. Virol. 74: 10458-10467 [Abstract] [Full Text]  
• Janz, A., Oezel, M., Kurzeder, C., Mautner, J., Pich, D., Kost, M., Hammerschmidt, W., Delecluse, H.-J. (2000). Infectious Epstein-Barr Virus Lacking Major Glycoprotein BLLF1 (gp350/220) Demonstrates the Existence of Additional Viral Ligands. J. Virol. 74: 10142-10152 [Abstract] [Full Text]  
• Marchbank, K. J., Watson, C. C., Ritsema, D. F., Holers, V. M. (2000). Expression of Human Complement Receptor 2 (CR2, CD21) in Cr2-/- Mice Restores Humoral Immune Function. J. Immunol. 165: 2354-2361 [Abstract] [Full Text]  
• Molesworth, S. J., Lake, C. M., Borza, C. M., Turk, S. M., Hutt-Fletcher, L. M. (2000). Epstein-Barr Virus gH Is Essential for Penetration of B Cells but Also Plays a Role in Attachment of Virus to Epithelial Cells. J. Virol. 74: 6324-6332 [Abstract] [Full Text]  
• Borza, C. M., Hutt-Fletcher, L. M. (1998). Epstein-Barr Virus Recombinant Lacking Expression of Glycoprotein gp150 Infects B Cells Normally but Is Enhanced for Infection of Epithelial Cells. J. Virol. 72: 7577-7582 [Abstract] [Full Text]  
• Boyle, K. A., Compton, T. (1998). Receptor-Binding Properties of a Soluble Form of Human Cytomegalovirus Glycoprotein B. J. Virol. 72: 1826-1833 [Abstract] [Full Text]  
• Sixbey, J., Yao, Q. (1992). Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 255: 1578-1580 [Abstract]